Invesco Biotechnology & Genome ETF
PBE
PBE
70 hedge funds and large institutions have $116M invested in Invesco Biotechnology & Genome ETF in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
70
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.52M | |
| 2 | +$1.31M | |
| 3 | +$238K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$168K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$158K |
Top Sellers
| 1 | -$1.66M | |
| 2 | -$1.58M | |
| 3 | -$1.21M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$844K |
| 5 |
CWM
Concert Wealth Management
San Jose,
California
|
-$804K |